您的位置: 首页 > 农业专利 > 详情页

Chimeric Antigen Receptor, Nucleic Acid, Chimeric Antigen Receptor Expression Plasmid, Chimeric Antigen Receptor Expressing Cell, Use Thereof, and Pharmaceutical Composition for Treating Cancer
专利权人:
China Medical University Hospital
发明人:
CHO, Der-Yang,CHIU, Shao-Chih,JAN, Chia-Ing,PAN, Chih-Ming,HUANG, Shi-Wei
申请号:
AU2019206018
公开号:
AU2019206018A1
申请日:
2019.07.16
申请国别(地区):
AU
年份:
2020
代理人:
摘要:
#$%^&*AU2019206018A120200402.pdf#####ABSTRACT The present disclosure relates to a chimeric antigen receptor, a nucleic acid, a chimeric antigen receptor expression plasmid, a chimeric antigen receptor expressing cell, a pharmaceutical composition for treating cancer, and use of the chimeric antigen receptor expressing cell. The chimeric antigen receptor is specific to human leukocyte antigen G. The nucleic acid encodes the chimeric antigen receptor. The chimeric antigen receptor expression plasmid expresses the chimeric antigen receptor. The chimeric antigen receptor expressing cell is obtained by transducing the chimeric antigen receptor into an immune cell. The pharmaceutical composition for treating cancer includes the chimeric antigen receptor expressing cell and a pharmaceutically acceptable carrier. A2)
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充